Through the Net Zero World Initiative, expertise from DOE national laboratories will be harnessed to put global net zero within reach.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Fundamental research conducted at the $90-million research facility will help the nation meet its clean energy goals.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

PNNL researchers can make methane from captured CO2 and renewably sourced hydrogen, offering a path toward cheaper synthetic natural gas.

Hypergraphs can more faithfully identify important genes in complex immune responses.

PNNL researchers are forming a clearer picture of how plant matter is transformed in the microbial gardens created by leaf-cutter ants.

The web-based tool, called PLATIPUS, is publicly available and interacts with publications available in the CovidScholar database.

PNNL computational scientist Diana Bacon’s role as carbon storage associate editor uses her expertise in subsurface modeling and quantitative risk assessment.

New quantum chemistry pipeline can help predict the effects of bioengineering.

U.S. Secretary of Energy Jennifer M. Granholm virtually visits PNNL, one of several national lab visits she is conducting.

High-throughput biochemical assays targeting a vital viral protein identified one molecule out of more than 13,000 with promising antiviral activity against SARS-CoV-2.

Understanding lipid composition of ant fungal gardens provides new knowledge on interkingdom communications band and also advances toward the development of microbial systems that can produce valuable compounds from plant biomass.

PNNL’s newest solvent captures carbon dioxide from power plants for as little as $47.10 per metric ton, marking a significant milestone in the journey to lower the cost of carbon capture.

Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.

PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.

Pacific Northwest National Laboratory (PNNL) researchers pioneer a new tool to represent cellular response to viral infection.

By studying discrete functional components of the soil microbiome at high resolution, researchers obtained a more complete picture of soil diversity compared to analysis of the entire soil community.

Researchers trained deep neural networks to accurately predict microbial interactions captured by fluorescence microscopy.

Six months into a pandemic that has claimed more than 570,000 lives worldwide, scores of PNNL scientists are engaged in dozens of projects in the fight against COVID-19.